Orthofix International (OFIX) Tops Q3 EPS by 7c; Trims Guidance Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Shipping stocks on fire — but cracks are forming in the rate rally
Orthofix Reports Third Quarter 2022 Results
November 3, 2022 7:00 AM EDTNet sales of $114.0 million, an increase of 1% on a reported basis and 5% on a constant currency basis over prior year Global Orthopedics net sales growth of 19% on a constant currency basis driven by new product and channel investments GAAP EPS of ($0.53) and adjusted EPS of $0.13 Orthofix and MTF Biologics recognized with the 2022 Spine Technology Award from Orthopedics This Week for Virtuos Lyograft, the first of its kind, shelf-stable and complete autograft substitute Announced agreement to merge with SeaSpine, creating a leading global spine and... More
